Loading...
Identification of HDAC Inhibitors with Benzoylhydrazide scaffold that Selectively Inhibit Class I HDACs
Inhibitors of histone deacetylases (HDACi) hold a considerable therapeutic promise as clinical anticancer therapies. However, currently known HDACi exhibit limited isoform specificity, off-target activity, and undesirable pharmaceutical properties. Thus, HDACi with new chemotypes are needed to overc...
Na minha lista:
| Udgivet i: | Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4365786/ https://ncbi.nlm.nih.gov/pubmed/25699604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2014.12.015 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|